Urteste S.A. (WSE:URT)
Poland · Delayed Price · Currency is PLN 49.10
-0.20 (-0.41%)
Jul 18, 2025, 4:45 PM CET
Urteste Company Description
Urteste S.A. engages in the research and development of diagnostic tests for cancers.
It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, stomach, lung, oesophagus, ovary, endometrium, blood, breast, and nervous system cancer.
The company was incorporated in 2021 and is based in Gdansk, Poland.
Urteste S.A.
| Country | Poland |
| Founded | 2021 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 20 |
| CEO | Grzegorz Stefanski |
Contact Details
Address: ul. Starodworska 1 Gdansk, 80-137 Poland | |
| Website | urteste.com |
Stock Details
| Ticker Symbol | URT |
| Exchange | Warsaw Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| ISIN Number | PLURTST00010 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Grzegorz Stefanski | President of the Management Board |
| Tomasz Kostuch | Member of the Management Board |